Accelero Bioanalytics GmbH (“Accelero”) announces the acquisition by the CCR Group B.V. Amsterdam, an integrated Contract Research Organization active in testing for the pharmaceutical, (agro)chemical and biotech industry.
Accelero is a GLP and GCP qualified laboratory, with a strong focus on providing services in regulatory non-clinical and clinical development of Advanced Therapy Medicinal Products (ATMP) and biologics. The company is also active in biosafety testing and biological Research and Development. The acquisition strengthens the geographical footprint and reinforces CCR’s platform to further accelerate the deployment of desired testing methodologies to support the pharmaceutical and biotech industries across the entire drug development cycle.
“On behalf of all Accelero employees I am happy to join the CCR family as a new integral part. Accelero complements CCR’s activities with its non-clinical and clinical expertise for their international clients. This partnership will enable CCR´s clients to benefit from a broader service portfolio and will promote Accelero to the next level of expansion. The entire Accelero team is very much looking forward to adding value to CCR´s customers,” said Christian Lange, MD of Accelero.
CEO of CCR, Dr. Marleen van Nuenen adds: “With the acquisition of Accelero Bioanalytics, CCR is expanding its portfolio in the GLP and GCP testing area for biopharmaceutical companies. This acquisition is in line with our growth strategy and vision to serve high-demanding customers in different stages of the development of their (biological)drugs. We look forward to strengthening Accelero’s testing portfolio and operating footprint by providing access to the full range of services, capabilities, and knowledge of CCR.”
Accelero is a certified GLP test facility and operates in compliance with ICH GCP regulations. Accelero offers services for research areas like Nucleic Acid-based therapeutics and Advanced Therapy Medicinal Products (ATMP) like genetically modified virus-based gene therapy vectors. The assay portfolio includes qPCR, immunogenicity testing, flow cytometry, and ELISA. Accelero serves biopharmaceutical companies all over the world.
CCR is a Contract Research Organization with multiple laboratory sites in Germany and the Netherlands offering a comprehensive spectrum of integrated services to the pharmaceutical, (agro)chemical and biotech industry. CCR serves customers all over the world spanning across Europe, Asia and the US. The overall portfolio of competencies is consistent with the global needs in (bio)pharmaceutical and (agro)chemical testing services.
Please click hereto download the complete press release.